Literature DB >> 15564441

Reducing arginase activity via dietary manganese deficiency enhances endothelium-dependent vasorelaxation of rat aorta.

Jodi L Ensunsa1, J David Symons, Louise Lanoue, Heather R Schrader, Carl L Keen.   

Abstract

L-Arginine is a common substrate for the enzymes arginase and nitric oxide synthase (NOS). Acute inhibition of arginase enzyme activity improves endothelium-dependent vasorelaxation, presumably by increasing availability of substrate for NOS. Arginase is activated by manganese (Mn), and the consumption of a Mn-deficient (Mn-) diet can result in low arginase activity. We hypothesize that endothelium-dependent vasorelaxation is greater in rats fed Mn- versus Mn sufficient (Mn+) diets. Newly weaned rats fed Mn+ diets (0.5 microg Mn/g; n = 12) versus Mn+ diets (45 microg Mn/g; n = 12) for 44 +/- 3 days had (i) lower liver and kidney Mn and arginase activity (P < or = 0.05), (ii) higher plasma L-arginine (P < or = 0.05), (iii) similar plasma and urine nitrate + nitrite, and (iv) similar staining for endothelial nitric oxide synthase in thoracic aorta. Vascular reactivity of thoracic aorta (approximately 720 microm i.d.) and small coronary arteries (approximately 110 microm i.d.) was evaluated using wire myographs. Acetylcholine (ACh; 10(-8)-10(-4) M) produced greater (P < or = 0.05) vasorelaxation in thoracic aorta from Mn- rats (e.g., maximal percent relaxation, 79 +/- 7%) versus Mn + rats (e.g., maximal percent relaxation, 54 +/- 9%) at 5 of 7 evaluated doses. Tension produced by NOS inhibition using N(G) monomethyl-L-arginine (L-NMMA; 10(-3) M) and vasorelaxation evoked by (i) arginase inhibition using difluoromethylornithine (DFMO; 10(-7) M), (ii) ACh (10(-8)-10(-4) M) in the presence of DFMO, and (iii) sodium nitroprusside (10(-9)-10(-4) M) were unaffected by diet. No differences existed between groups concerning these responses in small coronary arteries. These findings support our hypothesis that endothelium-dependent vasorelaxation is greater in aortic segments from rats that consume Mn- versus Mn+ diets; however, responses from small coronary arteries were unaffected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564441     DOI: 10.1177/153537020422901109

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.

Authors:  J David Symons; Ping Hu; Ying Yang; Xiaohui Wang; Quan-Jiang Zhang; Adam R Wende; Crystal L Sloan; Sandra Sena; E Dale Abel; Sheldon E Litwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

2.  Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.

Authors:  B Blairanne Williams; Gunnar F Kwakye; Michal Wegrzynowicz; Daphne Li; Michael Aschner; Keith M Erikson; Aaron B Bowman
Journal:  Toxicol Sci       Date:  2010-06-13       Impact factor: 4.849

3.  Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I.

Authors:  Wei Wang; Travis W Hein; Cuihua Zhang; David C Zawieja; James C Liao; Lih Kuo
Journal:  Microcirculation       Date:  2011-01       Impact factor: 2.628

Review 4.  Cardiovascular toxicities upon manganese exposure.

Authors:  Yueming Jiang; Wei Zheng
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

5.  Arginase inhibition alleviates hypertension in the metabolic syndrome.

Authors:  Hany M El-Bassossy; Rania El-Fawal; Ahmed Fahmy; Malcolm L Watson
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

6.  Rat strains bred for low and high aerobic running capacity do not differ in their survival time to hemorrhage.

Authors:  Harold G Klemcke; Kathy L Ryan; Steven L Britton; Lauren G Koch; Michael A Dubick; Victor A Convertino
Journal:  Exp Biol Med (Maywood)       Date:  2009-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.